FIL Limited - Net Worth and Insider Trading
FIL Limited Net Worth
The estimated net worth of FIL Limited is at least $261 Million dollars as of 2024-10-02. FIL Limited is the 2201 Interest of corporation controlled by you of Cutia Therapeutics and owns about 17,440,385 shares of Cutia Therapeutics (HKSE:02487) stock worth over $261 Million. Details can be seen in FIL Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that FIL Limited has not made any transactions after 2024-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of FIL Limited
FIL Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, FIL Limited owns 1 companies in total, including Cutia Therapeutics (HKSE:02487) .
Click here to see the complete history of FIL Limited’s form 4 insider trades.
Insider Ownership Summary of FIL Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02487 | Cutia Therapeutics | 2024-05-31 | 2201 Interest of corporation controlled by you |
FIL Limited Latest Holdings Summary
FIL Limited currently owns a total of 1 stock. FIL Limited owns 17,440,385 shares of Cutia Therapeutics (HKSE:02487) as of May 28, 2024, with a value of $261 Million.
Latest Holdings of FIL Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02487 | Cutia Therapeutics | 2024-05-28 | 17,440,385 | 14.94 | 260,559,352 |
Holding Weightings of FIL Limited
FIL Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, FIL Limited has made a total of 5 transactions in Cutia Therapeutics (HKSE:02487) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Cutia Therapeutics is the sale of 1,529,200 shares on May 28, 2024, which brought FIL Limited around $14 Million.
Insider Trading History of FIL Limited
- 1
FIL Limited Trading Performance
GuruFocus tracks the stock performance after each of FIL Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by FIL Limited is -1.64%. GuruFocus also compares FIL Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by FIL Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how FIL Limited's insider trading performs compared to the benchmark.
Performance of FIL Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.81 |  | | | | |
| Relative Return to S&P 500(%) | 4.9 | | | | | |
FIL Limited Ownership Network
FIL Limited Owned Company Details
What does Cutia Therapeutics do?
Who are the key executives at Cutia Therapeutics?
FIL Limited is the 2201 Interest of corporation controlled by you of Cutia Therapeutics. Other key executives at Cutia Therapeutics include 2201 Interest of corporation controlled by you Pandanus Partners L.P. , 2201 Interest of corporation controlled by you Pandanus Associates Inc. , and 2201 Interest of corporation controlled by you Shen Nan Peng .
Cutia Therapeutics (HKSE:02487) Insider Trades Summary
Over the past 18 months, FIL Limited made 5 insider transaction in Cutia Therapeutics (HKSE:02487) with a net sale of 3,165,600. Other recent insider transactions involving Cutia Therapeutics (HKSE:02487) include a net sale of 3,165,600 shares made by Pandanus Partners L.P. , a net sale of 3,165,600 shares made by Pandanus Associates Inc. , and a net sale of 0 shares made by Ma Yun .
In summary, during the past 3 months, insiders sold 0 shares of Cutia Therapeutics (HKSE:02487) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,994,200 shares of Cutia Therapeutics (HKSE:02487) were sold and 497,400 shares were bought by its insiders, resulting in a net sale of 9,496,800 shares.
Cutia Therapeutics (HKSE:02487)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cutia Therapeutics Insider Transactions
FIL Limited Mailing Address
Above is the net worth, insider trading, and ownership report for FIL Limited. Currently GuruFocus does not have mailing address information for FIL Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
